163 related articles for article (PubMed ID: 2014965)
1. Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
Potel G; Caillon J; Fantin B; Raza J; Le Gallou F; Lepage JY; Le Conte P; Bugnon D; Baron D; Drugeon H
Antimicrob Agents Chemother; 1991 Jan; 35(1):111-6. PubMed ID: 2014965
[TBL] [Abstract][Full Text] [Related]
2. Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis.
Potel G; Caillon J; Le Gallou F; Bugnon D; Le Conte P; Raza J; Lepage JY; Baron D; Drugeon H
Antimicrob Agents Chemother; 1992 Apr; 36(4):744-50. PubMed ID: 1503436
[TBL] [Abstract][Full Text] [Related]
3. Gentamicin-resistant Serratia marcescens endophthalmitis.
Gammon JA; Schwab I; Joseph P
Arch Ophthalmol; 1980 Jul; 98(7):1221-3. PubMed ID: 6994702
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the bactericidal activity of three aminosides: gentamicin, tobramycin and amikacin].
Juvin ME; Drugeon HB; Caillon J; Pirault JL
Pathol Biol (Paris); 1987 May; 35(5):461-5. PubMed ID: 3302848
[TBL] [Abstract][Full Text] [Related]
5. The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.
Dubé L; Caillon J; Jacqueline C; Bugnon D; Potel G; Asseray N
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2545-7. PubMed ID: 22395262
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
7. In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model.
Bugnon D; Potel G; Xiong YQ; Caillon J; Kergueris MF; Le Conte P; Baron D; Drugeon H
Antimicrob Agents Chemother; 1996 May; 40(5):1164-9. PubMed ID: 8723459
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of five aminoglycosides for treatment.
Rosin H; Naumann P; Reintjens E; Köhler M
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
[TBL] [Abstract][Full Text] [Related]
9. Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa.
Omri A; Ravaoarinoro M; Poisson M
J Antimicrob Chemother; 1995 Oct; 36(4):631-9. PubMed ID: 8591937
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
Watanakunakorn C
Antimicrob Agents Chemother; 1983 Aug; 24(2):305-6. PubMed ID: 6314890
[TBL] [Abstract][Full Text] [Related]
11. Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.
Meyer RD; Lewis RP; Halter J; White M
Lancet; 1976 Mar; 1(7959):580-3. PubMed ID: 55850
[TBL] [Abstract][Full Text] [Related]
12. Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens.
Langstaff D; Schueler S; Righter J
J Antimicrob Chemother; 1983 Feb; 11(2):187-9. PubMed ID: 6339461
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE; Packer RR
Antimicrob Agents Chemother; 1980 Aug; 18(2):338-45. PubMed ID: 7447410
[TBL] [Abstract][Full Text] [Related]
15. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
Jotzoff M
Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
[TBL] [Abstract][Full Text] [Related]
16. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
Rubens CE; McGee ZA; Farrar WE
J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
DiPersio JR; Krafczyk TL
Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Drugeon HB; Courtieu AL
Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
[TBL] [Abstract][Full Text] [Related]
19. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
De Broe ME; Giuliano RA; Verpooten GA
Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
Lode H; Grunert K; Kemmerich B; Koeppe P
Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
